Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000930413-11-004214
Filing Date
2011-06-02
Accepted
2011-06-02 13:45:04
Documents
1
Period of Report
2011-06-01

Document Format Files

Seq Description Document Type Size
1 c65851.html 4  
1 c65851.xml 4 3075
  Complete submission text file 0000930413-11-004214.txt   4750
Mailing Address 20 KINGSBRIDGE ROAD ATT: GENERAL COUNSEL PISCATAWAY NJ 08854
Business Address 20 KINGSBRIDGE ROAD ATT: GENERAL COUNSEL PISCATAWAY NJ 08854 732-980-4500
ENZON PHARMACEUTICALS INC (Issuer) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 222 S 15TH STREET SUITE 600 N OMAHA NE 68102
Business Address
LEBUHN ROBERT (Reporting) CIK: 0001007931 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-12957 | Film No.: 11887881